The KEEPS-cognitive and affective study: Baseline associations between vascular risk factors and cognition

Whitney Wharton, Carey E. Gleason, N. Maritza Dowling, Cynthia M. Carlsson, Eliot A. Brinton, M. Nanette Santoro, Genevieve Neal-Perry, Hugh Taylor, Frederick Naftolin, Rogerio A. Lobo, George Merriam, Joann E. Manson, Marcelle I. Cedars, Virginia M Miller, Dennis M. Black, Matthew Budoff, Howard N. Hodis, S. Mitchell Harman, Sanjay Asthana

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Midlife vascular risk factors influence later cognitive decline and Alzheimer's disease (AD). The decrease in serum estradiol levels during menopause has been associated with cognitive impairment and increased vascular risk, such as high blood pressure (BP), which independently contributes to cognitive dysfunction and AD. We describe the extent to which vascular risk factors relate to cognition in healthy, middle-aged, recently postmenopausal women enrolled in the Kronos Early Estrogen Prevention Cognitive and Affective Study (KEEPS-Cog) at baseline. KEEPS-Cog is a double-blind, randomized, placebo-controlled, parallel group, clinical trial, investigating the efficacy of low-dose, transdermal 17β-estradiol and oral conjugated equine estrogen on cognition. All results are cross-sectional and represent baseline data only. Analyses confirm that the KEEPS-Cog cohort (n = 571) was middle aged (mean 52.7 years, range 42-59 years), healthy, and free of cognitive dysfunction. Higher systolic BP was weakly related to poorer performance in auditory working memory and attention (p = 0.004; adjusted for multiple comparisons p = 0.10). This relationship was not associated with endogenous hormone levels, and systolic BP was not related to any other cognitive domain. BP levels may be more sensitive than other vascular risk factors in detecting subtle differences in cognitive task performance in healthy, recently menopausal women. Lower BP early in menopause may affect cognitive domains known to be associated with AD.

Original languageEnglish (US)
Pages (from-to)331-341
Number of pages11
JournalJournal of Alzheimer's Disease
Volume40
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Cognition
Blood Pressure
Alzheimer Disease
Menopause
Estradiol
Hypertension
Conjugated (USP) Estrogens
Task Performance and Analysis
Short-Term Memory
Blood Vessels
Estrogens
Placebos
vascular factor
Clinical Trials
Hormones
Cognitive Dysfunction
Serum

Keywords

  • Attention
  • blood pressure
  • clinical trial
  • cognition
  • estradiol
  • estrogen
  • hormone therapy
  • memory
  • vascular risk

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Medicine(all)

Cite this

Wharton, W., Gleason, C. E., Dowling, N. M., Carlsson, C. M., Brinton, E. A., Santoro, M. N., ... Asthana, S. (2014). The KEEPS-cognitive and affective study: Baseline associations between vascular risk factors and cognition. Journal of Alzheimer's Disease, 40(2), 331-341. https://doi.org/10.3233/JAD-130245

The KEEPS-cognitive and affective study : Baseline associations between vascular risk factors and cognition. / Wharton, Whitney; Gleason, Carey E.; Dowling, N. Maritza; Carlsson, Cynthia M.; Brinton, Eliot A.; Santoro, M. Nanette; Neal-Perry, Genevieve; Taylor, Hugh; Naftolin, Frederick; Lobo, Rogerio A.; Merriam, George; Manson, Joann E.; Cedars, Marcelle I.; Miller, Virginia M; Black, Dennis M.; Budoff, Matthew; Hodis, Howard N.; Harman, S. Mitchell; Asthana, Sanjay.

In: Journal of Alzheimer's Disease, Vol. 40, No. 2, 2014, p. 331-341.

Research output: Contribution to journalArticle

Wharton, W, Gleason, CE, Dowling, NM, Carlsson, CM, Brinton, EA, Santoro, MN, Neal-Perry, G, Taylor, H, Naftolin, F, Lobo, RA, Merriam, G, Manson, JE, Cedars, MI, Miller, VM, Black, DM, Budoff, M, Hodis, HN, Harman, SM & Asthana, S 2014, 'The KEEPS-cognitive and affective study: Baseline associations between vascular risk factors and cognition', Journal of Alzheimer's Disease, vol. 40, no. 2, pp. 331-341. https://doi.org/10.3233/JAD-130245
Wharton, Whitney ; Gleason, Carey E. ; Dowling, N. Maritza ; Carlsson, Cynthia M. ; Brinton, Eliot A. ; Santoro, M. Nanette ; Neal-Perry, Genevieve ; Taylor, Hugh ; Naftolin, Frederick ; Lobo, Rogerio A. ; Merriam, George ; Manson, Joann E. ; Cedars, Marcelle I. ; Miller, Virginia M ; Black, Dennis M. ; Budoff, Matthew ; Hodis, Howard N. ; Harman, S. Mitchell ; Asthana, Sanjay. / The KEEPS-cognitive and affective study : Baseline associations between vascular risk factors and cognition. In: Journal of Alzheimer's Disease. 2014 ; Vol. 40, No. 2. pp. 331-341.
@article{dd4cc448b3bc4d1f926ff30227a3da61,
title = "The KEEPS-cognitive and affective study: Baseline associations between vascular risk factors and cognition",
abstract = "Midlife vascular risk factors influence later cognitive decline and Alzheimer's disease (AD). The decrease in serum estradiol levels during menopause has been associated with cognitive impairment and increased vascular risk, such as high blood pressure (BP), which independently contributes to cognitive dysfunction and AD. We describe the extent to which vascular risk factors relate to cognition in healthy, middle-aged, recently postmenopausal women enrolled in the Kronos Early Estrogen Prevention Cognitive and Affective Study (KEEPS-Cog) at baseline. KEEPS-Cog is a double-blind, randomized, placebo-controlled, parallel group, clinical trial, investigating the efficacy of low-dose, transdermal 17β-estradiol and oral conjugated equine estrogen on cognition. All results are cross-sectional and represent baseline data only. Analyses confirm that the KEEPS-Cog cohort (n = 571) was middle aged (mean 52.7 years, range 42-59 years), healthy, and free of cognitive dysfunction. Higher systolic BP was weakly related to poorer performance in auditory working memory and attention (p = 0.004; adjusted for multiple comparisons p = 0.10). This relationship was not associated with endogenous hormone levels, and systolic BP was not related to any other cognitive domain. BP levels may be more sensitive than other vascular risk factors in detecting subtle differences in cognitive task performance in healthy, recently menopausal women. Lower BP early in menopause may affect cognitive domains known to be associated with AD.",
keywords = "Attention, blood pressure, clinical trial, cognition, estradiol, estrogen, hormone therapy, memory, vascular risk",
author = "Whitney Wharton and Gleason, {Carey E.} and Dowling, {N. Maritza} and Carlsson, {Cynthia M.} and Brinton, {Eliot A.} and Santoro, {M. Nanette} and Genevieve Neal-Perry and Hugh Taylor and Frederick Naftolin and Lobo, {Rogerio A.} and George Merriam and Manson, {Joann E.} and Cedars, {Marcelle I.} and Miller, {Virginia M} and Black, {Dennis M.} and Matthew Budoff and Hodis, {Howard N.} and Harman, {S. Mitchell} and Sanjay Asthana",
year = "2014",
doi = "10.3233/JAD-130245",
language = "English (US)",
volume = "40",
pages = "331--341",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - The KEEPS-cognitive and affective study

T2 - Baseline associations between vascular risk factors and cognition

AU - Wharton, Whitney

AU - Gleason, Carey E.

AU - Dowling, N. Maritza

AU - Carlsson, Cynthia M.

AU - Brinton, Eliot A.

AU - Santoro, M. Nanette

AU - Neal-Perry, Genevieve

AU - Taylor, Hugh

AU - Naftolin, Frederick

AU - Lobo, Rogerio A.

AU - Merriam, George

AU - Manson, Joann E.

AU - Cedars, Marcelle I.

AU - Miller, Virginia M

AU - Black, Dennis M.

AU - Budoff, Matthew

AU - Hodis, Howard N.

AU - Harman, S. Mitchell

AU - Asthana, Sanjay

PY - 2014

Y1 - 2014

N2 - Midlife vascular risk factors influence later cognitive decline and Alzheimer's disease (AD). The decrease in serum estradiol levels during menopause has been associated with cognitive impairment and increased vascular risk, such as high blood pressure (BP), which independently contributes to cognitive dysfunction and AD. We describe the extent to which vascular risk factors relate to cognition in healthy, middle-aged, recently postmenopausal women enrolled in the Kronos Early Estrogen Prevention Cognitive and Affective Study (KEEPS-Cog) at baseline. KEEPS-Cog is a double-blind, randomized, placebo-controlled, parallel group, clinical trial, investigating the efficacy of low-dose, transdermal 17β-estradiol and oral conjugated equine estrogen on cognition. All results are cross-sectional and represent baseline data only. Analyses confirm that the KEEPS-Cog cohort (n = 571) was middle aged (mean 52.7 years, range 42-59 years), healthy, and free of cognitive dysfunction. Higher systolic BP was weakly related to poorer performance in auditory working memory and attention (p = 0.004; adjusted for multiple comparisons p = 0.10). This relationship was not associated with endogenous hormone levels, and systolic BP was not related to any other cognitive domain. BP levels may be more sensitive than other vascular risk factors in detecting subtle differences in cognitive task performance in healthy, recently menopausal women. Lower BP early in menopause may affect cognitive domains known to be associated with AD.

AB - Midlife vascular risk factors influence later cognitive decline and Alzheimer's disease (AD). The decrease in serum estradiol levels during menopause has been associated with cognitive impairment and increased vascular risk, such as high blood pressure (BP), which independently contributes to cognitive dysfunction and AD. We describe the extent to which vascular risk factors relate to cognition in healthy, middle-aged, recently postmenopausal women enrolled in the Kronos Early Estrogen Prevention Cognitive and Affective Study (KEEPS-Cog) at baseline. KEEPS-Cog is a double-blind, randomized, placebo-controlled, parallel group, clinical trial, investigating the efficacy of low-dose, transdermal 17β-estradiol and oral conjugated equine estrogen on cognition. All results are cross-sectional and represent baseline data only. Analyses confirm that the KEEPS-Cog cohort (n = 571) was middle aged (mean 52.7 years, range 42-59 years), healthy, and free of cognitive dysfunction. Higher systolic BP was weakly related to poorer performance in auditory working memory and attention (p = 0.004; adjusted for multiple comparisons p = 0.10). This relationship was not associated with endogenous hormone levels, and systolic BP was not related to any other cognitive domain. BP levels may be more sensitive than other vascular risk factors in detecting subtle differences in cognitive task performance in healthy, recently menopausal women. Lower BP early in menopause may affect cognitive domains known to be associated with AD.

KW - Attention

KW - blood pressure

KW - clinical trial

KW - cognition

KW - estradiol

KW - estrogen

KW - hormone therapy

KW - memory

KW - vascular risk

UR - http://www.scopus.com/inward/record.url?scp=84901949958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901949958&partnerID=8YFLogxK

U2 - 10.3233/JAD-130245

DO - 10.3233/JAD-130245

M3 - Article

C2 - 24430001

AN - SCOPUS:84901949958

VL - 40

SP - 331

EP - 341

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -